Boston U. Researcher Presses Ahead With Plans to Publish Cancer Study That IBM Wants to Stifle

By GOLDIE BLUMENSTYK

A JURY OF PEERS: Richard W. Clapp's study of cancer risks among semiconductor workers at IBM manufacturing plants never made it to a widely watched trial in which the corporation prevailed in February.

But the study, which suggested that those workers were at greater risk of dying of cancer than average Americans were, may yet see the light of day in a medical journal, despite IBM's insistence that publication would violate a court order.

In his study, Mr. Clapp, a professor of